Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen H O Hoffmann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Acta Dermato-Venereologica|October 18, 2012
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse eventsVera Seidling, Jochen H O Hoffmann, Alexander H Enk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2019
Pyodermatitis-Pyostomatitis vegetans mit histologischen und immunhistologischen Aspekten einer bullösen Autoimmunerkrankung therapiert mit InfliximabInes Bertlich, Annika Gauss, Knut Schäkel, et al.
Journal of Dermatological Science|October 13, 2014
Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patientsJochen H O Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica|April 27, 2021
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment CyclesJochen H O Hoffmann, Christian Knoop, Knut Schäkel, et al.
The Journal of Dermatology|January 20, 2021
Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patientsJochen H O Hoffmann, Christian Knoop, Kunt Schäkel, et al.
Experimental Dermatology|June 17, 2016
Interindividual variation of NETosis in healthy donors: introduction and application of a refined method for extracellular trap quantificationJochen H O Hoffmann, Knut Schaekel, Maria R Gaiser, et al.
JAMA Dermatology|March 21, 2019
Overlap of Bullous, Anti-Laminin-332, and Anti-p200 Pemphigoid With Concomitant Anti-Contactin-1-Positive Inflammatory Polyneuropathy Treated With Intravenous Immunoglobulins as a Manifestation of Epitope SpreadingAlexander Wald, Enno Schmidt, Ferdinand Toberer, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 13, 2015
Synaptic Conductance Estimates of the Connection Between Local Inhibitor Interneurons and Pyramidal Neurons in Layer 2/3 of a Cortical ColumnJochen H O Hoffmann, H S Meyer, Arno C Schmitt, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Dermato-Venereologica|October 18, 2012
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse eventsVera Seidling, Jochen H O Hoffmann, Alexander H Enk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2019
Pyodermatitis-Pyostomatitis vegetans mit histologischen und immunhistologischen Aspekten einer bullösen Autoimmunerkrankung therapiert mit InfliximabInes Bertlich, Annika Gauss, Knut Schäkel, et al.
Journal of Dermatological Science|October 13, 2014
Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patientsJochen H O Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica|April 27, 2021
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment CyclesJochen H O Hoffmann, Christian Knoop, Knut Schäkel, et al.
The Journal of Dermatology|January 20, 2021
Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patientsJochen H O Hoffmann, Christian Knoop, Kunt Schäkel, et al.
Experimental Dermatology|June 17, 2016
Interindividual variation of NETosis in healthy donors: introduction and application of a refined method for extracellular trap quantificationJochen H O Hoffmann, Knut Schaekel, Maria R Gaiser, et al.
JAMA Dermatology|March 21, 2019
Overlap of Bullous, Anti-Laminin-332, and Anti-p200 Pemphigoid With Concomitant Anti-Contactin-1-Positive Inflammatory Polyneuropathy Treated With Intravenous Immunoglobulins as a Manifestation of Epitope SpreadingAlexander Wald, Enno Schmidt, Ferdinand Toberer, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 13, 2015
Synaptic Conductance Estimates of the Connection Between Local Inhibitor Interneurons and Pyramidal Neurons in Layer 2/3 of a Cortical ColumnJochen H O Hoffmann, H S Meyer, Arno C Schmitt, et al.
Pageof 2